Lv1
70 积分 2025-01-16 加入
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
2个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
2个月前
已完结
Single-cell and spatial transcriptomics of stricturing Crohn’s disease highlights a fibrosis-associated network
5个月前
已完结
皖公网安备34019202002308
